Sarah Halford

5PUBLICATIONS
48CO-AUTHORS
Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Emergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Improving preclinical and clinical oncology research through patient integration.

Steve Clark, Rachel Grimley, Sarah Halford

|Jan 07, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

|Jan 12, 2024
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status.

Ali Jn Duabil, Christian R Cooper, Esraa Aldujaily

|Jan 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Sarah Halford, Gareth J Veal, Stephen R Wedge

|Aug 20, 2021
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.

Sarah Halford, Susan Wan, Ilaria Dragoni

Pageof 1

Frequent Collaborators

1 joint publications

Christian R Cooper

1 joint publications

Sidath D Katugampola

1 joint publications

George Dd Jones

1 joint publications

Gareth J Veal